Literature DB >> 19523722

Quantitative structure activity relationship (QSAR) of piperine analogs for bacterial NorA efflux pump inhibitors.

Amit Nargotra1, Sujata Sharma, Jawahir Lal Koul, Pyare Lal Sangwan, Inshad Ali Khan, Ashwani Kumar, Subhash Chander Taneja, Surrinder Koul.   

Abstract

Quantitative structure activity relationship (QSAR) analysis of piperine analogs as inhibitors of efflux pump NorA from Staphylococcus aureus has been performed in order to obtain a highly accurate model enabling prediction of inhibition of S. aureus NorA of new chemical entities from natural sources as well as synthetic ones. Algorithm based on genetic function approximation method of variable selection in Cerius2 was used to generate the model. Among several types of descriptors viz., topological, spatial, thermodynamic, information content and E-state indices that were considered in generating the QSAR model, three descriptors such as partial negative surface area of the compounds, area of the molecular shadow in the XZ plane and heat of formation of the molecules resulted in a statistically significant model with r(2)=0.962 and cross-validation parameter q(2)=0.917. The validation of the QSAR models was done by cross-validation, leave-25%-out and external test set prediction. The theoretical approach indicates that the increase in the exposed partial negative surface area increases the inhibitory activity of the compound against NorA whereas the area of the molecular shadow in the XZ plane is inversely proportional to the inhibitory activity. This model also explains the relationship of the heat of formation of the compound with the inhibitory activity. The model is not only able to predict the activity of new compounds but also explains the important regions in the molecules in quantitative manner.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19523722     DOI: 10.1016/j.ejmech.2009.05.004

Source DB:  PubMed          Journal:  Eur J Med Chem        ISSN: 0223-5234            Impact factor:   6.514


  7 in total

1.  Discovery of new Mycobacterium tuberculosis proteasome inhibitors using a knowledge-based computational screening approach.

Authors:  Rukmankesh Mehra; Reena Chib; Gurunadham Munagala; Kushalava Reddy Yempalla; Inshad Ali Khan; Parvinder Pal Singh; Farrah Gul Khan; Amit Nargotra
Journal:  Mol Divers       Date:  2015-08-01       Impact factor: 2.943

2.  Escaping mechanisms of ESKAPE pathogens from antibiotics and their targeting by natural compounds.

Authors:  Ragi Jadimurthy; Shilpa Borehalli Mayegowda; S Chandra Nayak; Chakrabhavi Dhananjaya Mohan; Kanchugarakoppal S Rangappa
Journal:  Biotechnol Rep (Amst)       Date:  2022-04-04

3.  Thai ethnomedicinal plants as resistant modifying agents for combating Acinetobacter baumannii infections.

Authors:  Pinanong Na Phatthalung; Sasitorn Chusri; Supayang P Voravuthikunchai
Journal:  BMC Complement Altern Med       Date:  2012-04-26       Impact factor: 3.659

4.  A mass spectrometry-based assay for improved quantitative measurements of efflux pump inhibition.

Authors:  Adam R Brown; Keivan A Ettefagh; Daniel Todd; Patrick S Cole; Joseph M Egan; Daniel H Foil; Tyler N Graf; Bryan D Schindler; Glenn W Kaatz; Nadja B Cech
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

5.  Microbial efflux systems and inhibitors: approaches to drug discovery and the challenge of clinical implementation.

Authors:  Christina Kourtesi; Anthony R Ball; Ying-Ying Huang; Sanjay M Jachak; D Mariano A Vera; Proma Khondkar; Simon Gibbons; Michael R Hamblin; George P Tegos
Journal:  Open Microbiol J       Date:  2013-03-22

Review 6.  Recent Advances in Multi-Drug Resistance (MDR) Efflux Pump Inhibitors of Gram-Positive Bacteria S. aureus.

Authors:  Jadwiga Handzlik; Anna Matys; Katarzyna Kieć-Kononowicz
Journal:  Antibiotics (Basel)       Date:  2013-02-05

7.  Homology modeling, molecular dynamics, and virtual screening of NorA efflux pump inhibitors of Staphylococcus aureus.

Authors:  Baki Vijaya Bhaskar; Tirumalasetty Muni Chandra Babu; Netala Vasudeva Reddy; Wudayagiri Rajendra
Journal:  Drug Des Devel Ther       Date:  2016-10-03       Impact factor: 4.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.